Programmed cell death 10 increased blood-brain barrier permeability through HMGB1/TLR4 mediated downregulation of endothelial ZO-1 in glioblastoma

被引:7
|
作者
Wu, Sisi [1 ]
Wang, Junwen [1 ]
Liu, Jingdian [1 ]
Zhu, Hongtao [1 ]
Li, Ran [1 ]
Wan, Xueyan [1 ]
Lei, Jin [1 ]
Li, Yu [1 ]
You, Chao [1 ]
Hu, Feng [1 ]
Zhang, Suojun [1 ]
Zhao, Kai [1 ,2 ]
Shu, Kai [1 ,2 ]
Lei, Ting [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Jiefang Ave 1095, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
Programmed cell death 10 (PDCD10); Glioblastoma (GBM); Blood brain barrier (BBB); Tight junction (TJ); High mobility group box 1 (HMGB1); Toll like receptor 4 (TLR4); CEREBRAL CAVERNOUS MALFORMATIONS; TIGHT JUNCTIONS; CLAUDIN-5; CCM3; EXPRESSION; OCCLUDIN; DISTINCT; MODELS;
D O I
10.1016/j.cellsig.2023.110683
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dysfunction of blood brain barrier (BBB) contributes to the development of peritumoral edema (PTE) and GBM progression. Programmed cell death 10 (PDCD10) exerts various influence on cancers, especially in glioblastoma (GBM). We previously found that PDCD10 expression was positively correlated with PTE extent in GBM. Thus, the present study aims to investigate the emerging role of PDCD10 in regulating BBB permeability in GBM. Here we found that in vitro indirect co-culture of endothelial cells (ECs) with Pdcd10-overexpressed GL261 cells resulted in a significant increase of FITC-Dextran (MW, 4000) leakage by reducing endothelial zonula occluden-1 (ZO-1) and Claudin-5 expression in ECs respectively. Overexpression of Pdcd10 in GBM cells (GL261) triggered an increase of soluble high mobility group box 1 (HMGB1) release, which in turn activated endothelial toll like receptor 4 (TLR4) and downstream NF-kappa B, Erk1/2 and Akt signaling in ECs through a paracrine manner. Moreover, Pdcd10-overexpressed GL261 cells facilitated a formation of abnormal vasculature and increased the BBB permeability in vivo. Our present study demonstrates that upregulation of PDCD10 in GBM triggered HMGB1/TLR4 signaling in ECs and significantly decreased endothelial ZO-1 expression, which in turn dominantly increased BBB permeability and contributed to tumor progression in GBM.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Vascular endothelial growth factor aggravates cerebral ischemia and reperfusion-induced blood-brain-barrier disruption through regulating LOC102640519/HOXC13/ZO-1 signaling
    Wu, Li
    Ye, Zeming
    Pan, Ying
    Li, Xianliang
    Fu, Xian
    Zhang, Bo
    Li, Youfu
    Lin, Wanrong
    Li, Xuelong
    Gao, Qingchun
    EXPERIMENTAL CELL RESEARCH, 2018, 369 (02) : 275 - 283
  • [42] HIV-1 gp120 enhances Cryptococcus neoformans-mediated blood-brain barrier disruption in an in vitro human brain microvascular endothelial cell model
    Cao, H. D.
    Xie, J. F.
    Lin, Q. X.
    Wan, Y.
    Gong, Z.
    Long, M.
    Cao, H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 297 - 297
  • [43] Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss
    Chen, Shuang
    Sun, Yanyun
    Li, Fei
    Zhang, Xinyu
    Hu, Xiaoyan
    Zhao, Xiaoyun
    Li, Yixuan
    Li, Hui
    Zhang, Jianliang
    Liu, Wenlan
    Zheng, Guo-qing
    Jin, Xinchun
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (07) : 2407 - 2422
  • [44] Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease
    Gan, Ping
    Ding, Lidong
    Hang, Guihua
    Xia, Qiaofang
    Huang, Zhimei
    Ye, Xing
    Qian, Xiaojuan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [45] Disruption of blood-brain barrier and endothelial-to-mesenchymal transition are attenuated by Astragalus polysaccharides mediated through upregulation of ETS1 expression in experimental autoimmune encephalomyelitis
    Lu, Qijin
    Ma, Jinyun
    Zhao, Yan
    Ding, Guiqing
    Wang, Yuanhua
    Qiao, Xi
    Cheng, Xiaodong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [46] CCCTC-binding factor-mediated microRNA-340-5p suppression aggravates myocardial injury in rats with severe acute pancreatitis through activation of the HMGB1/TLR4 axis
    Gao, Yazhou
    Gao, Yanxia
    Niu, Zequn
    Liu, Jie
    Feng, Hui
    Sun, Jiangli
    Wang, Liming
    Pan, Longfei
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (03) : 306 - 315
  • [47] Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways
    Piao, Yihua
    Jiang, Jingzhi
    Wang, Zhiguang
    Wang, Chongyang
    Jin, Shan
    Li, Li
    Li, Liangchang
    Piao, Hongmei
    Jin, Zhehu
    Zhu, Lianhua
    Yan, Guanghai
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [48] Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein a enhance traversal of Escherichia coli across the blood-brain barrier
    Prasadarao, NV
    Wass, CA
    Kim, KS
    INFECTION AND IMMUNITY, 1996, 64 (01) : 154 - 160
  • [49] Hyperglycemia Aggravates Blood–Brain Barrier Disruption Following Diffuse Axonal Injury by Increasing the Levels of Inflammatory Mediators through the PPARγ/Caveolin-1/TLR4 Pathway
    Xing Wei
    Yaqing Zhou
    Jinning Song
    Junjie Zhao
    Tingqin Huang
    Ming Zhang
    Yonglin Zhao
    Inflammation, 2023, 46 : 129 - 145
  • [50] Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model
    Ahmed, Mohammed H. H.
    Hernandez-Verdin, Isaias
    Quissac, Emie
    Lemaire, Nolwenn
    Guerin, Coralie
    Guyonnet, Lea
    Zahr, Noel
    Mouton, Laura
    Santin, Mathieu
    Petiet, Alexandra
    Schmitt, Charlotte
    Bouchoux, Guillaume
    Canney, Michael
    Sanson, Marc
    Verreault, Maite
    Carpentier, Alexandre
    Idbaih, Ahmed
    PHARMACEUTICS, 2023, 15 (02)